Together, the five companies represent nearly 95 percent of the hip and knee replacement market. Each company was accused of “using consulting agreements with orthopedic surgeons as inducements to use a particular company’s artificial hip and knee reconstruction and replacement products” between at least 2002 and 2006. In addition to such agreements, which allegedly paid surgeons tens to hundreds of thousands of dollars per year, the companies are also alleged to have provided doctors with trips and other perks.
A complete copy of the U.S. Attorney’s press release can be found here.